
Omnicell
Update in progressOMCL (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryHealth Information Services
Omnicell, Inc., with its subsidiaries, provides healthcare technology for the United States and international markets. It offers hospital and health system solutions, including clinician workflow points of care, Titan XT automated dispensing, XT cabinet extensions, and Central Pharmacy Dispensing. It also delivers Central Med Automation, IV Compounding, specialty pharmacy services, EnlivenHealth, medication adherence products, and OmniSphere cloud platform, plus post-install support and maintenance.
Company score
- Sentiment
- 0.28
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.25
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.18
- Governance
- 0.15
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.17
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.22
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
No news articles are available for this company yet.
Unable to load company news.
You're all caught up!